Sex-Specific Survival Bias and Interaction Modeling in Coronary Artery Disease Risk Prediction

Background: The 10-year Atherosclerotic Cardiovascular Disease risk score is the standard approach to predict risk of incident cardiovascular events, and recently, addition of coronary artery disease (CAD) polygenic scores has been evaluated. Although age and sex strongly predict the risk of CAD, their interaction with genetic risk prediction has not been systematically examined. This study performed an extensive evaluation of age and sex effects in genetic CAD risk prediction. Methods: The population-based Norwegian HUNT2 (Trøndelag Health Study 2) cohort of 51 036 individuals was used as the primary dataset. Findings were replicated in the UK Biobank (372 410 individuals). Models for 10-year CAD risk were fitted using Cox proportional hazards, and Harrell concordance index, sensitivity, and specificity were compared. Results: Inclusion of age and sex interactions of CAD polygenic score to the prediction models increased the C-index and sensitivity by accounting for nonadditive effects of CAD polygenic score and likely countering the observed survival bias in the baseline. The sensitivity for females was lower than males in all models including genetic information. We identified a total of 82.6% of incident CAD cases by using a 2-step approach: (1) Atherosclerotic Cardiovascular Disease risk score (74.1%) and (2) the CAD polygenic score interaction model for those in low clinical risk (additional 8.5%). Conclusions: These findings highlight the importance and complexity of genetic risk in predicting CAD. There is a need for modeling age- and sex-interaction terms with polygenic scores to optimize detection of individuals at high risk, those who warrant preventive interventions. Sex-specific studies are needed to understand and estimate CAD risk with genetic information.

[1]  J. Danesh,et al.  Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses , 2021, PLoS medicine.

[2]  Yan V. Sun,et al.  Sexual Differences in Genetic Predisposition of Coronary Artery Disease. , 2020, Circulation. Genomic and precision medicine.

[3]  Theresa M. Beckie,et al.  Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. , 2020, Circulation.

[4]  Chiadi E. Ndumele,et al.  Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index , 2020, JAMA network open.

[5]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[6]  M. Nöthen,et al.  Risk prediction for coronary heart disease by a genetic risk score - results from the Heinz Nixdorf Recall study , 2020, BMC medical genetics.

[7]  G. McVean,et al.  The impact of age on genetic risk for common diseases , 2021, PLoS genetics.

[8]  D. Grobbee,et al.  Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya , 2020, International journal of cardiology. Heart & vasculature.

[9]  Audrey Y. Chu,et al.  Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers , 2020, Nature Medicine.

[10]  P. Elliott,et al.  Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. , 2020, JAMA.

[11]  Benjamin Neale,et al.  Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention , 2019 .

[12]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[13]  L. Hooft,et al.  Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis , 2019, BMC Medicine.

[14]  Alicia R. Martin,et al.  Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.

[15]  J. Shaw,et al.  External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study , 2019, The Medical journal of Australia.

[16]  E. Boersma,et al.  Cardiovascular risk prediction models for women in the general population: A systematic review , 2019, PloS one.

[17]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[18]  G. Abecasis,et al.  Improving power of association tests using multiple sets of imputed genotypes from distributed reference panels , 2017, Genetic epidemiology.

[19]  A. Khera,et al.  Genetics of coronary artery disease: discovery, biology and clinical translation , 2017, Nature Reviews Genetics.

[20]  Markus Perola,et al.  Genomic prediction of coronary heart disease , 2016, bioRxiv.

[21]  J. Catanese,et al.  Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history , 2015, European heart journal.

[22]  Olle Melander,et al.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.

[23]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[24]  T. Wadden,et al.  Reprint: 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. , 2014, Journal of the American Pharmacists Association : JAPhA.

[25]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[26]  K. Hveem,et al.  COHORT PROFILE Cohort Profile : The HUNT Study , Norway , 2013 .

[27]  John P A Ioannidis,et al.  Comparisons of established risk prediction models for cardiovascular disease: systematic review , 2012, BMJ : British Medical Journal.

[28]  Carol Coupland,et al.  Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database , 2010, BMJ : British Medical Journal.

[29]  G. Boysen,et al.  European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.

[30]  I. Njølstad,et al.  [Model for estimation of cardiovascular risk in Norway]. , 2008, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[31]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.